Skip to main content
. 2018 Jul 5;13(1):74. doi: 10.1007/s11657-018-0487-8

Fig. 1.

Fig. 1

Kaplan-Meier survival curve for persistence rates with once-daily teriparatide in patients enrolled (yes) and not enrolled (no) in the patient-support program during the 24-month observation period. *One patient in the no group did not have data for initiation of teriparatide administration